Investors evaluating small-cap healthcare technology often weigh companies at different stages of maturity, and that contrast is central to this BFLY versus QSI stock comparison. Butterfly Network (BFLY) is commercializing a semiconductor-based handheld ultrasound platform, while Quantum-Si (QSI) is developing single-molecule protein sequencing. Both address large life-science markets, yet their current revenue, momentum, and risk profiles sit at opposite ends of the spectrum. This comparison is most relevant for growth-oriented traders and investors who want to understand how relative performance, market positioning, and near-term catalysts differ between an emerging commercial business and a pre-launch platform company.
Butterfly Network (BFLY) develops handheld, whole-body ultrasound devices built on its proprietary Ultrasound-on-Chip semiconductor technology, paired with cloud software and AI tools. The company serves the point-of-care ultrasound (POCUS) market across enterprise healthcare, home and community care, and an "Embedded" licensing segment in which its chip and software are integrated into third-party products.
Recent market activity has been favorable. In its latest reported quarter, BFLY posted revenue above consensus estimates and raised its full-year guidance, citing strength in its Embedded partnerships, where revenue grew sharply year over year, and improved gross margin. The company has also expanded enterprise software deals and announced plans for new product launches in 2027. These execution-driven developments have supported a notable year-to-date share-price advance that has outpaced the S&P 500, reflecting improved sentiment around its path toward profitability.
Quantum-Si (QSI) is a proteomics company working to commercialize single-molecule protein sequencing, a technology that reads proteins one molecule at a time to unlock functional and structural insights. Its current commercial product is the Platinum instrument, but investor attention centers on Proteus, its next-generation platform intended to offer higher throughput, longer read lengths, and broader amino-acid detection.
Recent weeks have brought mixed signals. The company reported modest, declining revenue as customers await Proteus, and it delayed the platform's commercial launch from late 2026 to the second quarter of 2027 after an additional design cycle. At the same time, QSI announced meaningful technology milestones, including detecting 19 of 20 amino acids on Proteus, a workforce reduction to extend its cash runway, and a return to Nasdaq minimum-bid-price compliance. The shares have risen sharply year to date, driven more by technology progress and sentiment than by near-term financial results.
Tickeron operates hundreds of AI trading bots that collectively monitor and trade thousands of different tickers, each built around its own trading style, strategy, timeframe, and statistical profile. Because no single bot fits every market, Tickeron curates the best-performing and most suitable options into its Trending AI Robots section, where traders can browse bots by strategy, performance, and the tickers they cover. These bots range across momentum, swing, and intraday approaches, with varying win rates, trade counts, and drawdown profiles, giving users a way to align automation with their own risk preferences and current market conditions. Explore the Trending AI Robots page to review the available bots and identify candidates suited to your approach.
The most fundamental contrast is stage of commercialization. BFLY already generates tens of millions of dollars in quarterly revenue, has a growing installed base, and is improving gross margin, giving its valuation a tangible financial anchor. QSI reported only a few hundred thousand dollars in quarterly revenue, making its valuation almost entirely dependent on the future success of Proteus.
Growth drivers also differ. BFLY is scaling through Embedded licensing deals, enterprise software adoption, and geographic expansion. QSI is betting on a single high-impact product launch, with upside tied to the non-human proteomics market and post-translational modification (PTM) analysis.
Risk factors reflect these profiles. BFLY still reports operating losses and faces execution and competitive risks, but its balance sheet and revenue trajectory offer greater visibility. QSI carries elevated technology risk, a delayed launch timeline, and the possibility of future capital needs, which is compounded by its low share price and recent listing-compliance episode.
Based on observable factors such as trend consistency, financial stability, and near-term catalysts, Tickeron's AI would likely favor BFLY in the current environment. The stock has demonstrated a more sustained, execution-driven uptrend backed by rising revenue, improving margins, and raised guidance, characteristics that generally align with more stable momentum and lower volatility relative to its peer. By contrast, QSI offers a higher-conviction, event-driven setup around Proteus, but its price action has been more sentiment-led and its fundamentals thinner. While neither outcome is certain, a probability-weighted assessment of trend quality and positioning currently skews toward BFLY for traders prioritizing consistency and relative stability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +6.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 185 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 130 of 156 cases where BFLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
The 10-day RSI Indicator for BFLY moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for BFLY turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
BFLY moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BFLY crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
BFLY broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.982) is normal, around the industry mean (2.923). P/E Ratio (-24.483) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (16.556) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The 10-day moving average for QSI crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
QSI moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +12.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where QSI advanced for three days, in 156 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 95 of 122 cases where QSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for QSI moved out of overbought territory on October 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 23 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QSI as a result. In 83 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QSI turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 40 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
QSI broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.494) is normal, around the industry mean (2.923). P/E Ratio (-2.674) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (100.000) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. QSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BFLY | QSI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 91 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 32 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 98 | |
PRICE GROWTH RATING 1..100 | 36 | 36 | |
P/E GROWTH RATING 1..100 | 52 | 88 | |
SEASONALITY SCORE 1..100 | 32 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BFLY's Valuation (15) in the null industry is in the same range as QSI (32). This means that BFLY’s stock grew similarly to QSI’s over the last 12 months.
BFLY's Profit vs Risk Rating (100) in the null industry is in the same range as QSI (100). This means that BFLY’s stock grew similarly to QSI’s over the last 12 months.
BFLY's SMR Rating (97) in the null industry is in the same range as QSI (98). This means that BFLY’s stock grew similarly to QSI’s over the last 12 months.
BFLY's Price Growth Rating (36) in the null industry is in the same range as QSI (36). This means that BFLY’s stock grew similarly to QSI’s over the last 12 months.
BFLY's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for QSI (88). This means that BFLY’s stock grew somewhat faster than QSI’s over the last 12 months.
| BFLY | QSI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 89% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 89% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 81% |
| Advances ODDS (%) | 11 days ago 82% | 2 days ago 80% |
| Declines ODDS (%) | 2 days ago 89% | 4 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 78% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BFLY’s FA Score shows that 1 FA rating(s) are green while QSI’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BFLY’s TA Score shows that 3 TA indicator(s) are bullish while QSI’s TA Score has 5 bullish TA indicator(s).
BFLY (@Medical/Nursing Services) experienced а -6.58% price change this week, while QSI (@Medical/Nursing Services) price change was -11.51% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
BFLY is expected to report earnings on Oct 29, 2026.
QSI is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, BFLY has been loosely correlated with PACB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BFLY jumps, then PACB could also see price increases.
| Ticker / NAME | Correlation To BFLY | 1D Price Change % | ||
|---|---|---|---|---|
| BFLY | 100% | -2.87% | ||
| PACB - BFLY | 52% Loosely correlated | +9.18% | ||
| TXG - BFLY | 45% Loosely correlated | +5.78% | ||
| QSI - BFLY | 44% Loosely correlated | +6.03% | ||
| CERS - BFLY | 41% Loosely correlated | +3.46% | ||
| NTRA - BFLY | 38% Loosely correlated | +1.84% | ||
More | ||||
A.I.dvisor indicates that over the last year, QSI has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To QSI | 1D Price Change % | ||
|---|---|---|---|---|
| QSI | 100% | +6.03% | ||
| AXON - QSI | 49% Loosely correlated | +2.54% | ||
| PACB - QSI | 49% Loosely correlated | +9.18% | ||
| VCYT - QSI | 47% Loosely correlated | +3.19% | ||
| BFLY - QSI | 43% Loosely correlated | -2.87% | ||
| MESO - QSI | 39% Loosely correlated | +3.38% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| YNOT | 31.66 | 0.53 | +1.71% |
| Horizon Digital Frontier ETF (YNOT) | |||
| KOOL | 14.74 | 0.13 | +0.87% |
| North Shore Equity Rotation ETF | |||
| UGL | 44.97 | 0.29 | +0.65% |
| ProShares Ultra Gold (UGL) | |||
| ALDB | 26.07 | 0.15 | +0.56% |
| Aptus Laddered Deep Buffer ETF (ALDB) | |||
| DFCF | 40.40 | -0.01 | -0.02% |
| Dimensional Core Fixed Income ETF (DFCF) | |||